Among the targets of NF-κB are BCL-XL, BFL-1/A1, and possibly BCL-2, whose high expression as a result of NF-κB signaling may contribute to apoptosis resistance in ABC-DLBCL (52–54). Here, NFKB1 is linked to diffuse large B-cell lymphoma.